Current Medicinal Chemistry

Killing Time for Cancer Stem Cells (CSC): Discovery and Development of Selective CSC Inhibitors
pp. 1719-1725(7)
Authors: Perez-Caro, Maria; Sanchez-Garcia, Isidro

Emerging Role of Intravascular Ultrasound in the Assessment of Experimental Anti-Atherosclerotic Therapies
pp. 1727-1734(8)
Authors: Nicholls, Stephen J.; Sipahi, Ilke

Bringing Kinases Into Focus: Efficient Drug Design Through the Use of Chemogenomic Toolkits
pp. 1735-1748(14)
Authors: Birault, Veronique; Harris, C. J.; Le, Joelle; Lipkin, Mike; Nerella, Ravi; Stevens, Adrian

Antiviral and Immunomodulatory Properties of New Pro-Glutathione (GSH) Molecules
pp. 1749-1755(7)
Authors: Fraternale, A.; Paoletti, M. F.; Casabianca, A.; Oiry, J.; Clayette, P.; Vogel, J.- U.; Jr. Cinatl, J.; Palamara, A. T.; Sgarbanti, R.; Garaci, E.; Millo, E.; Benatti, U.; Magnani, M.

Delivering Drugs to the Central Nervous System: A Medicinal Chemistry or a Pharmaceutical Technology Issue?
pp. 1757-1775(19)
Authors: Ricci, Maurizio; Blasi, Paolo; Giovagnoli, Stefano; Rossi, Carlo

Novel Therapeutics for Diabetic Micro- and Macrovascular Complications
pp. 1777-1788(12)
Authors: Soro-Paavonen, A.; Forbes, J. M.

Carbon Nanotubes: Materials for Medicinal Chemistry and Biotechnological Applications
pp. 1789-1798(10)
Authors: Pagona, Georgia; Tagmatarchis, Nikos

Therapeutic Applications of Glycosaminoglycans
pp. 1799-1810(12)
Author: Volpi, Nicola

Development of BACE1 Inhibitors for Alzheimer's Disease
pp. 1811-1829(19)
Authors: Guo, Tao; Hobbs, Doug W.

Clinical Proteomics: New Trends for Protein Microarrays
pp. 1831-1837(7)
Authors: Becker, K.- F.; Metzger, V.; Hipp, S.; Hofler, H.

Small Molecule Glucokinase Activators as Glucose Lowering Agents: A New Paradigm for Diabetes Therapy
pp. 1839-1843(5)
Authors: Guertin, Kevin R.; Grimsby, Joseph